Health

Mile Marker Launches With New Business Momentum With Growth-Oriented Brands
Boehringer's zongertinib receives Priority Review from U.S. FDA for the treatment of HER2 (ERBB2)-mutant advanced non-small cell lung cancer
Garmin announces fourth quarter and fiscal year 2024 results
PTC Therapeutics Announces FDA Acceptance and Priority Review for Vatiquinone NDA for the Treatment of Children and Adults with Friedreich's Ataxia
Oncolytics Biotech® Advances Key Pancreatic and Anal Cancer Trials, Strengthening Pipeline in 2025
BluMaiden Biosciences Appoints New US-based Leadership to Accelerate Global Expansion
PAM Health Announces Plans to Build 42-bed Rehab Hospital in Carmel, Indiana
Lumeris Introduces Tom™, an AI-Powered Breakthrough to Transform Primary Care
CKGSB and Johns Hopkins University Launch AI-Driven Healthcare Innovation Program
Ona Therapeutics Strengthens Leadership Team to Accelerate First-in-Class ADCs into Clinical Development Across Cancer Types
Photocure ASA: Results for the fourth quarter of 2024
Frontier Scientific Solutions' Free Trade Zone Advantage Becomes Critical Amid Tariff Changes, Strengthening Life Sciences Supply Chain
Coway stellt Corporate Value-Up Plan mit Umsatzziel von 5 Billionen KRW im Jahr 2027 vor
'I discovered my fat build-up condition after a Love Islander had it'
Berlin Heals Holding AG réussit à lever plus de 7 millions de francs suisses pour lancer les premières études sur de nouvelles approches moins invasives
Coway presenta un plan corporativo de aumento de valor con un objetivo de ingresos para 2027
Cancer patients not getting right care, say doctors
Numinus Wellness Inc. Announces CFO Transition
BioVaxys Announces Debt Settlement Agreement, Extension of Private Placement Closing Date and Closing of The Fourth and Final Tranche of Private Placement
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Walgreens Boots Alliance, Inc. and Certain Officers - WBA